Lagos: The Society for Cellular Pathology Scientists of Nigeria (SCPSN) has called for the adoption of 'Genomic Testing' to enhance the diagnosis, treatment, and prevention of cancer in the country. Dr. Jonathan Madukwe, the National President of SCPSN, made this appeal during the eighth International Scientific Conference/Annual General Meeting of the association held in Lagos.
According to News Agency of Nigeria, the conference, themed 'Application of Genomic Testing for Improved Diagnosis, Treatment and Prevention of Cancer,' highlighted genomic testing as an advanced method in cancer management. Dr. Madukwe explained that this form of testing involves analyzing genetic, molecular, and heterogeneous factors contributing to cancer. He also identified lifestyle changes, environmental influences, and dietary habits as significant contributors to the disease.
Dr. Madukwe emphasized the importance of awareness regarding these risk factors and urged individuals to avoid them to reduce cancer incidence. He noted that environmental and lifestyle changes over the past decade have affected cancer cells, leading to an increase in cases. He advocated for regular screening and early detection, asserting their importance in effective cancer management and prevention.
Professor Francisca Nwokorie from the University of Lagos also supported the use of genomic testing, citing its accuracy and reliability in providing results for palliative care. She stressed the need for collaboration and awareness programs to educate the public and enhance access to genomic testing. Professor Nwokorie called on the Federal Government to facilitate the provision of genomic testing equipment due to its high cost.
Mr. Daniel Osiagwu, Chairman of the Local Organising Committee, encouraged the public to embrace genomic testing for effective treatment. He urged the government to implement policies to subsidize the cost of genomic testing equipment to improve accessibility and affordability.
Additionally, Mr. Joseph Ogunwuyi, Chairman of the occasion and Founding Father of the society, highlighted the conference as a platform for scientists to collaborate, innovate, and enhance histopathology practices. He advocated for the integration of Artificial Intelligence in pathology for better healthcare outcomes.
The event also featured the presentation of awards to individuals who have significantly contributed to the association's growth.